The global rabies veterinary vaccines market size reached US$ 587 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 757 Million by 2028, exhibiting a growth rate (CAGR) of 4.10% during 2023-2028. The increasing awareness among the masses, rapid globalization and urbanization activities, imposition of various government regulations, continuous evolution of the rabies virus, increasing international travel, and growing consumer expenditure capacities are some of the major factors propelling the market.
|Market Size in 2022
||US$ 587 Million
|Market Forecast in 2028
||US$ 757 Million
|Market Growth Rate (2023-2028)
Rabies veterinary vaccines refer to specialized immunizing agents formulated to prevent the onset of rabies in animals. They are produced using inactivated or attenuated strains of the rabies virus. Rabies veterinary vaccines find extensive applications in domestic pets, livestock, wild animals, zoo animals, breeding establishments, animal shelters, travel or trade regulations, disease control programs, laboratory animal use, and public health initiatives. They aid in reducing disease spread, protecting human and animal health, enhancing public safety, supporting wildlife conservation, maintaining herd immunity, enhancing animal welfare, and facilitating international animal trade.
The continuous evolution of the rabies virus, which leads to the emergence of new strains that need targeted vaccines, is propelling the market growth. Furthermore, the increasing international travel, coupled with the escalating trade of animals, which requires proof of rabies vaccination, is boosting the market growth. Apart from this, the growing expenditure capacities, which allow individuals to own pets and invest in their healthcare, including vaccinations, are positively influencing the market growth. Additionally, the ongoing conservation efforts, especially for endangered species, which involve vaccinating wildlife, are contributing to the market growth. Moreover, the significant technological advancements within the field of veterinary medicine, which have led to more efficient and effective vaccines, are positively influencing the market growth. Other factors, including rising public health concerns, the rapid expansion of veterinary services, and increasing pet ownerships, are anticipated to drive the market growth.
Rabies Veterinary Vaccines Market Trends/Drivers:
The increasing awareness among the masses
The increasing awareness about the importance of rabies veterinary vaccines is a pivotal factor driving the market growth. In line with this, the ongoing public awareness campaigns, supported by government bodies, international organizations, and animal welfare groups to educate the population about rabies' fatal nature and the need for prevention through vaccination, are boosting the market growth. Furthermore, the increasing utilization of social media platforms, community outreach, educational programs, and veterinary services to provide information on the importance of timely vaccinations for both domestic and stray animals is positively influencing the market growth. Apart from this, the introduction of stringent laws regarding mandatory vaccination, owing to the growing awareness among the masses and government bodies, is fueling the market growth. Moreover, the unification of public interest, governmental backing, and active participation by the veterinary community is creating a robust system that encourages compliance with vaccination protocols.
The rapid globalization and urbanization activities
The significant growth of urban areas and increasing globalization are key driving forces for the rabies veterinary vaccines market. In line with this, the inclusion of previously remote or wild areas into the urban landscape, causing overlap between human populations and wildlife, which increases the potential for rabies transmission from wild animals to domestic pets and livestock, is acting as another growth-inducing factor. Furthermore, the growing demand for rigorous vaccination owing to rapid globalization, which leads to an increased movement of animals across borders for trade or companionship, is positively influencing the market growth. Additionally, the increasing urban planning, coupled with the complexity of ecosystems, leading to unintended proximity between domestic and wild animals, is fueling the market growth. Apart from this, the growing demand for vaccination programs that can act as a protective barrier, minimizing the spread of rabies within urbanized areas, is supporting the market growth.
The imposition of various government regulations
Government regulations pertaining to rabies vaccinations are instrumental in shaping the market for rabies veterinary vaccines. In line with this, the implementation of mandatory rabies vaccination laws for domestic pets, such as dogs and cats, is positively influencing the market growth. Furthermore, these legal frameworks are structured to protect public health and enhance animal welfare, given that rabies is a zoonotic disease with a very high fatality rate if left untreated. Moreover, they often work in conjunction with other measures, including licensing, microchipping, and regular veterinary check-ups, to create a comprehensive system that fosters responsible pet ownership. Additionally, the enforcement of these laws, which requires collaboration between various governmental departments, veterinary associations, and animal control authorities, is supporting the market growth. Along with this, the imposition of various government initiatives, such as subsidized or free vaccination campaigns in underserved areas, is catalyzing the market growth.
Rabies Veterinary Vaccines Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global rabies veterinary vaccines market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on application.
Breakup by Application:
- Companion Animals
- Livestock Animals
- Wildlife Animals
Companion Animals holds the largest market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes companion animals, livestock animals, and wildlife animals. According to the report, companion animals represented the largest market segment.
Companion animals are dominating the market growth owing to the imposition of various government regulations mandating vaccination to safeguard both human and animal health. Apart from this, the growing demand for vaccinating companion animals against rabies due to widespread awareness campaigns is favoring the market growth. In addition, the escalating human-animal interaction, which increases the risk of rabies transmission from companion animals, is fueling the market growth. Furthermore, the rising trend of pet ownership, which is facilitating the demand for vaccinations, including those for rabies, is positively influencing the market growth. Apart from this, the increasing international travel with companion animals, which often necessitates proof of rabies vaccination, is strengthening the market growth. Moreover, the presence of regular veterinary care for companion animals where vaccinations, including rabies, are standard is catalyzing the market growth.
Breakup by Region:
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
North America exhibits a clear dominance in the market, accounting for the largest rabies veterinary vaccines market share.
The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The imposition of strict regulations in North America mandating rabies vaccinations for pets, particularly dogs and cats, is propelling the market growth. Additionally, the widespread organization of awareness campaigns by regional governments educating the public about the importance of rabies vaccinations is contributing to the market growth. Apart from this, the presence of a highly developed veterinary healthcare infrastructure, which ensures that rabies vaccines are readily available to most pet owners, is positively influencing the market growth. In addition, the growing expenditure capacities of the regional population, which allows consumers to afford pets and fulfill their healthcare needs, is strengthening the market growth. Moreover, North America hosts leading pharmaceutical companies that are engaged in the development and production of rabies vaccines. Along with this, the introduction of strict regulations regarding animal travel both within and outside the region, which require proof of rabies vaccination, is boosting the market growth.
Leading companies are formulating new vaccines, improving existing ones, and tailoring vaccines for specific animal species or geographical regions. Furthermore, several key players are extending their distribution networks to reach emerging markets through partnerships, acquisitions, or establishing local subsidiaries. In addition, they are investing in state-of-the-art manufacturing processes and facilities to ensure high-quality vaccine production. Apart from this, leasing companies are introducing new vaccines with improved efficacy or targeting specific strains of the virus. Moreover, they are working closely with regulatory authorities to gain approvals for new products and align with legal requirements. Along with this, some companies are participating in community awareness programs, offering education about rabies prevention and the importance of vaccination. Besides this, they are focusing on sustainable practices in both production and distribution, reflecting a growing emphasis on corporate social responsibility.
The report has provided a comprehensive analysis of the competitive landscape in the global rabies veterinary vaccines market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Bharat Biotech
- Biogénesis Bagó
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Limited
- Merck & Co., Inc.
- Zoetis Inc.
Rabies Veterinary Vaccines Market Report Scope:
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
||Companion Animals, Livestock Animals, Wildlife Animals
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Bharat Biotech, Biogénesis Bagó, Boehringer Ingelheim International GmbH, Elanco, Indian Immunologicals Limited, Merck & Co., Inc., Virbac, Zoetis Inc., etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global rabies veterinary vaccines market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global rabies veterinary vaccines market?
- What is the impact of each driver, restraint, and opportunity on the global rabies veterinary vaccines market?
- What are the key regional markets?
- Which countries represent the most attractive rabies veterinary vaccines market?
- What is the breakup of the market based on application?
- Which is the most attractive application in the rabies veterinary vaccines market?
- What is the competitive structure of the global rabies veterinary vaccines market?
- Who are the key players/companies in the global rabies veterinary vaccines market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the rabies veterinary vaccines market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global rabies veterinary vaccines market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the rabies veterinary vaccines industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.